Search

Search Results
Results 2651 - 2660 of 2867 for Bowel Cancer
  • Pramin
    Drug - 21 Jan 2025
    Consumer Medicine Information (CMI) about Pramin intended for persons living in Australia.
  • Pamisol
    Drug - 14 Jan 2025
    Consumer Medicine Information (CMI) about Pamisol intended for persons living in Australia.
  • Kalixocin
    Drug - 14 Jan 2025
    Consumer Medicine Information (CMI) about Kalixocin intended for persons living in Australia.
  • Exploring the Connection Between Gut Health and Meditation
    Health - 12 Jan 2025
    In this Mediknowledge article, keynote contributor Dr. Balachundhar Subramaniam explores the connection between gut health and meditation.
  • Seasonique
    Drug - 17 Dec 2024
    Consumer Medicine Information (CMI) about Seasonique intended for persons living in Australia.
  • Moxicam Capsules
    Drug - 17 Dec 2024
    Consumer Medicine Information (CMI) about Moxicam Capsules intended for persons living in Australia.
  • Vitamin Malabsorption: A Comprehensive Guide from A to K
    Health - 6 Dec 2024
    Malabsorption disrupts vitamin absorption, leading to deficiencies in essential nutrients like A, D, E, K, C, and B12, with significant health implications.
  • Lasix and Lasix High Dose
    Drug - 26 Nov 2024
    Consumer Medicine Information (CMI) about Lasix and Lasix High Dose intended for persons living in Australia.
  • Candida Overgrowth in the Gut
    Health - 16 Oct 2024
    Candida overgrowth can disrupt gut health, leading to serious conditions. Explore the factors contributing to this issue and potential treatment approaches.
  • Myfortic
    Drug - 17 Sep 2024
    Consumer Medicine Information (CMI) about Myfortic intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback